Rosenblum; Michael G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rosenblum; Michael G..The latest application filed is for "serine protease molecules and therapies".
Company Profile
6.26.34
- Rosenblum; Michael G. - Sugar Land TX
- Rosenblum; Michael G. - Sugarland TX
- Rosenblum; Michael G. - Houston TX
- Rosenblum; Michael G. - US
Patent Activity
| Patent | Date |
|---|---|
| Serine protease molecules and therapies Grant 10,920,211 - Rosenblum , et al. February 16, 2 | 2021-02-16 |
| Serine Protease Molecules And Therapies App 20200308565 - ROSENBLUM; Michael G. ; et al. | 2020-10-01 |
| Serine protease molecules and therapies Grant 10,738,295 - Rosenblum , et al. A | 2020-08-11 |
| Serine Protease Molecules And Therapies App 20200010821 - ROSENBLUM; Michael G. ; et al. | 2020-01-09 |
| Serine Protease Molecules And Therapies App 20190256837 - ROSENBLUM; Michael G. ; et al. | 2019-08-22 |
| Serine protease molecules and therapies Grant 10,323,239 - Rosenblum , et al. | 2019-06-18 |
| Serine Protease Molecules And Therapies App 20180201918 - ROSENBLUM; Michael G. ; et al. | 2018-07-19 |
| Serine protease molecules and therapies Grant 9,951,325 - Rosenblum , et al. April 24, 2 | 2018-04-24 |
| Serine protease molecules and therapies Grant 9,499,807 - Rosenblum , et al. November 22, 2 | 2016-11-22 |
| Deimmunized gelonin molecules and therapies Grant 9,388,397 - Rosenblum , et al. July 12, 2 | 2016-07-12 |
| Deimmunized Gelonin Molecules And Therapies App 20150368628 - ROSENBLUM; Michael G. ; et al. | 2015-12-24 |
| Serine protease molecules and therapies Grant 9,096,840 - Rosenblum , et al. August 4, 2 | 2015-08-04 |
| Serine Protease Molecules And Therapies App 20150010556 - ROSENBLUM; Michael G. ; et al. | 2015-01-08 |
| Serine Protease Molecules And Therapies App 20140314760 - ROSENBLUM; Michael G. ; et al. | 2014-10-23 |
| Serine Protease Molecules And Therapies App 20140140976 - ROSENBLUM; Michael G. ; et al. | 2014-05-22 |
| Therapeutic agents comprising pro-apoptotic proteins Grant 8,530,225 - Rosenblum , et al. September 10, 2 | 2013-09-10 |
| Therapeutic Agents Comprising Pro-Apoptotic Proteins App 20120252097 - Rosenblum; Michael G. ; et al. | 2012-10-04 |
| Modified proteins, designer toxins, and methods of making thereof Grant 8,138,311 - Rosenblum , et al. March 20, 2 | 2012-03-20 |
| Modified Proteins, Designer Toxins, and Methods of Making Thereof App 20110288275 - Rosenblum; Michael G. ; et al. | 2011-11-24 |
| Therapeutic agents comprising pro-apoptotic proteins Grant 8,043,831 - Rosenblum , et al. October 25, 2 | 2011-10-25 |
| Modified proteins, designer toxins, and methods of making thereof Grant 7,943,571 - Rosenblum , et al. May 17, 2 | 2011-05-17 |
| Therapeutic Agents Comprising Pro-apoptotic Proteins App 20110002910 - Rosenblum; Michael G. ; et al. | 2011-01-06 |
| Modified Proteins, Designer Toxins, And Methods Of Making Thereof App 20100247518 - ROSENBLUM; MICHAEL G. ; et al. | 2010-09-30 |
| Fullerenes in targeted therapies Grant 7,758,889 - Sagman , et al. July 20, 2 | 2010-07-20 |
| Therapeutic agents comprising pro-apoptotic proteins Grant 7,759,091 - Rosenblum , et al. July 20, 2 | 2010-07-20 |
| Modified proteins, designer toxins, and methods of making thereof Grant 7,741,278 - Rosenblum , et al. June 22, 2 | 2010-06-22 |
| Multimodality Molecular Imaging With Therapeutic Conjugates App 20100068151 - Rosenblum; Michael G. ; et al. | 2010-03-18 |
| Targeted Nanostructures for Cellular Imaging App 20090214101 - Wilson; Lon J. ; et al. | 2009-08-27 |
| Therapeutic Agents Comprising Pro-Apoptotic Proteins App 20090010917 - Rosenblum; Michael G. ; et al. | 2009-01-08 |
| Modified Proteins, Designer Toxins, and Methods of Making Thereof App 20080292544 - Rosenblum; Michael G. ; et al. | 2008-11-27 |
| Use of Carbon Nanotube for Drug Delivery App 20080193490 - Hirsch; Andreas ; et al. | 2008-08-14 |
| Nanostructure-Drug Conjugates App 20080175892 - Wilson; Lon J. ; et al. | 2008-07-24 |
| Therapeutic agents comprising pro-apoptotic proteins Grant 7,371,723 - Rosenblum , et al. May 13, 2 | 2008-05-13 |
| Immunotoxins directed against CD33 related surface antigens App 20080089898 - Rosenblum; Michael G. | 2008-04-17 |
| Immunotoxins directed against CD33 related surface antigens Grant 7,297,335 - Rosenblum November 20, 2 | 2007-11-20 |
| Modified proteins, designer toxins, and methods of making thereof Grant 7,285,635 - Rosenblum , et al. October 23, 2 | 2007-10-23 |
| Cell-Targeted IKB and Methods for the Use Thereof App 20070202593 - Liu; Yuying ; et al. | 2007-08-30 |
| Modified proteins, designer toxins, and methods of making thereof App 20070036780 - Rosenblum; Michael G. ; et al. | 2007-02-15 |
| Vascular targeting of ocular neovascularization App 20070025957 - Rosenblum; Michael G. ; et al. | 2007-02-01 |
| Therapeutic agents comprising pro-apoptotic proteins App 20060280749 - Rosenblum; Michael G. ; et al. | 2006-12-14 |
| Targeted chimeric molecules for cancer therapy App 20060263368 - Rosenblum; Michael G. ; et al. | 2006-11-23 |
| Substituted fullerenes and their use as inhibitors of cell death App 20060247152 - Lebovitz; Russ ; et al. | 2006-11-02 |
| Therapeutic agents comprising pro-apoptotic proteins Grant 7,101,977 - Rosenblum , et al. September 5, 2 | 2006-09-05 |
| Targeted polypeptides App 20060171919 - Rosenblum; Michael G. ; et al. | 2006-08-03 |
| Modified proteins, designer toxins, and methods of making thereof Grant 7,083,957 - Rosenblum , et al. August 1, 2 | 2006-08-01 |
| Short carbon nanotubes as adsorption and retention agents App 20060051290 - Wilson; Lon J. ; et al. | 2006-03-09 |
| Antibody conjugates for treatment of neoplastic disease App 20050214307 - Rosenblum, Michael G. | 2005-09-29 |
| Novel antibody delivery system for biological response modifiers App 20050100528 - Rosenblum, Michael G. | 2005-05-12 |
| Antibody delivery system for biological response modifiers Grant 6,750,329 - Rosenblum , et al. June 15, 2 | 2004-06-15 |
| Immunotoxin as a therapeutic agent and uses thereof App 20040013691 - Rosenblum, Michael G. | 2004-01-22 |
| ImmunoConjucates for cancer diagnosis and therapy Grant 6,669,938 - Rosenblum , et al. December 30, 2 | 2003-12-30 |
| Modified proteins, designer toxins, and methods of making thereof App 20030176331 - Rosenblum, Michael G. ; et al. | 2003-09-18 |
| Immunotoxins directed against CD33 related surface antigens App 20030157092 - Rosenblum, Michael G. | 2003-08-21 |
| Immunotoxins directed against CD33 related surface antigens Grant 6,599,505 - Rosenblum July 29, 2 | 2003-07-29 |
| Therapeutic agents comprising pro-apoptotic proteins App 20030086919 - Rosenblum, Michael G. ; et al. | 2003-05-08 |
| Methods and systems for providing access to one or more databases of information concerning therepeutic and diagnostic agents App 20020055935 - Rosenblum, Michael G. | 2002-05-09 |
| Anti-IgM monoclonal antibodies and methods of their use Grant 6,306,626 - Rosenblum , et al. October 23, 2 | 2001-10-23 |
| Avidin-biotin immunoconjugates Grant 6,214,974 - Rosenblum , et al. April 10, 2 | 2001-04-10 |
| Interferon antibody therapeutic compositions having an extended serum half-life Grant 5,055,289 - Frincke , et al. October 8, 1 | 1991-10-08 |
Company Registrations
| NCAGE Code | 511H6 | ROSENBLUM, MICHAEL G |
| CAGE Code | 511H6 | ROSENBLUM, MICHAEL G |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 